Yeji
NDA/BLA filedconf 0.85

bbp-418 — NDA/BLA filed

$BBIO · BridgeBio Pharma, Inc. · LGMD2I/R9 (Limb-Girdle Muscular Dystrophy type 2I/R9)
Event date
Date TBD
Sponsor runway
13 mo
$879.9M liquid

Evidence

“BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced the submission of its New Drug Application (NDA) to the FDA for oral BBP-418 for the treatment of individuals living with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9).”
Source: Press release · 2026-03-30View press release ↗

Comparable historical nda/bla fileds· last 5 years · same event type

TickerDrugDateOutcome
$AXSM—2025-12-31unknown
$RCKTkresladi2025-10-14unknown
$ALDXreproxalap2025-07-17unknown
$ETONet-6002025-07-08unknown
$BCRXorladeyo (berotralstat)2025-05-14unknown
$CORTrelacorilant2025-03-03unknown
$ALDXreproxalap2024-11-01unknown
$AXSMaxs-072024-09-04unknown
$RCKTkresladi2023-10-02unknown
$GERNimetelstat2023-08-21unknown

Recent insider activity· ±90 days

4 insiders · 0 buys · 17 sells
Sell10b5-1
2026-05-18
Trimarchi Thomas
President and CFO
10,456 @ $64.82$678K
Sell10b5-1
2026-05-18
Trimarchi Thomas
President and CFO
3,195 @ $65.95$211K
Exercise
2026-05-16
Kumar Neil
Chief Executive Officer
19,599 @ ——
Exercise
2026-05-16
Kumar Neil
Chief Executive Officer
11,553 @ ——
Tax10b5-1
2026-05-16
Trimarchi Thomas
President and CFO
22,781 @ $66.13$1.51M
Tax
2026-05-16
Apuli Maricel
Chief Accounting Officer
4,714 @ $66.13$312K
Tax
2026-05-16
Kumar Neil
Chief Executive Officer
36,236 @ $66.13$2.40M
Exercise
2026-05-16
Kumar Neil
Chief Executive Officer
6,519 @ ——
Exercise
2026-05-16
Kumar Neil
Chief Executive Officer
33,544 @ ——
Exercise10b5-1
2026-05-15
Scott Randal W.
Director
10,000 @ $16.75$168K
Sell10b5-1
2026-05-15
Scott Randal W.
Director
6,200 @ $66.69$413K
Sell10b5-1
2026-05-15
Scott Randal W.
Director
2,088 @ $67.53$141K
Sell10b5-1
2026-05-15
Scott Randal W.
Director
1,512 @ $68.23$103K
Sell10b5-1
2026-05-15
Scott Randal W.
Director
200 @ $69.12$14K
Sell10b5-1
2026-05-08
Kumar Neil
Chief Executive Officer
5,076 @ $67.35$342K
Sell10b5-1
2026-05-08
Kumar Neil
Chief Executive Officer
13,973 @ $66.65$931K
Sell10b5-1
2026-05-08
Kumar Neil
Chief Executive Officer
5,077 @ $67.35$342K
Sell10b5-1
2026-05-08
Kumar Neil
Chief Executive Officer
950 @ $68.35$65K
Sell10b5-1
2026-05-08
Kumar Neil
Chief Executive Officer
13,974 @ $66.65$931K
Sell10b5-1
2026-05-07
Kumar Neil
Chief Executive Officer
449 @ $69.09$31K
Sell10b5-1
2026-05-07
Kumar Neil
Chief Executive Officer
11,217 @ $67.50$757K
Sell10b5-1
2026-05-07
Kumar Neil
Chief Executive Officer
8,333 @ $68.38$570K
Sell10b5-1
2026-05-07
Kumar Neil
Chief Executive Officer
450 @ $69.09$31K
Sell10b5-1
2026-05-07
Kumar Neil
Chief Executive Officer
8,334 @ $68.38$570K
Sell10b5-1
2026-04-30
Apuli Maricel
Chief Accounting Officer
2,000 @ $71.58$143K
← All catalysts for $BBIO